250 related articles for article (PubMed ID: 12954238)
1. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix.
Elsaid KA; Jay GD; Chichester CO
Osteoarthritis Cartilage; 2003 Sep; 11(9):673-80. PubMed ID: 12954238
[TBL] [Abstract][Full Text] [Related]
2. Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis.
Elsaid KA; Jay GD; Warman ML; Rhee DK; Chichester CO
Arthritis Rheum; 2005 Jun; 52(6):1746-55. PubMed ID: 15934070
[TBL] [Abstract][Full Text] [Related]
3. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
4. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
Lohmander LS; Atley LM; Pietka TA; Eyre DR
Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees.
Belcher C; Yaqub R; Fawthrop F; Bayliss M; Doherty M
Ann Rheum Dis; 1997 May; 56(5):299-307. PubMed ID: 9175930
[TBL] [Abstract][Full Text] [Related]
6. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
8. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.
Lohmander LS; Dahlberg L; Eyre D; Lark M; Thonar EJ; Ryd L
Osteoarthritis Cartilage; 1998 Sep; 6(5):351-61. PubMed ID: 10197170
[TBL] [Abstract][Full Text] [Related]
10. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
11. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
[TBL] [Abstract][Full Text] [Related]
12. Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation.
Ludwig TE; McAllister JR; Lun V; Wiley JP; Schmidt TA
Arthritis Rheum; 2012 Dec; 64(12):3963-71. PubMed ID: 22933061
[TBL] [Abstract][Full Text] [Related]
13. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
[TBL] [Abstract][Full Text] [Related]
14. Impaired glutathione reductase activity and levels of collagenase and elastase in synovial fluid in rheumatoid arthritis.
Bazzichi L; Ciompi ML; Betti L; Rossi A; Melchiorre D; Fiorini M; Giannaccini G; Lucacchini A
Clin Exp Rheumatol; 2002; 20(6):761-6. PubMed ID: 12508766
[TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage.
Noyori K; Koshino T; Takagi T; Okamoto R; Jasin HE
J Rheumatol; 1994 Feb; 21(2):293-6. PubMed ID: 8182639
[TBL] [Abstract][Full Text] [Related]
16. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury.
Hazell PK; Dent C; Fairclough JA; Bayliss MT; Hardingham TE
Arthritis Rheum; 1995 Jul; 38(7):953-9. PubMed ID: 7541993
[TBL] [Abstract][Full Text] [Related]
17. Increase in degraded collagen type II in synovial fluid early in the rabbit meniscectomy model of osteoarthritis.
Lindhorst E; Wachsmuth L; Kimmig N; Raiss R; Aigner T; Atley L; Eyre D
Osteoarthritis Cartilage; 2005 Feb; 13(2):139-45. PubMed ID: 15694575
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.
Matyas JR; Atley L; Ionescu M; Eyre DR; Poole AR
Arthritis Rheum; 2004 Feb; 50(2):543-52. PubMed ID: 14872497
[TBL] [Abstract][Full Text] [Related]
19. Lubricating ability of aspirated synovial fluid from emergency department patients with knee joint synovitis.
Jay GD; Elsaid KA; Zack J; Robinson K; Trespalacios F; Cha CJ; Chichester CO
J Rheumatol; 2004 Mar; 31(3):557-64. PubMed ID: 14994405
[TBL] [Abstract][Full Text] [Related]
20. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
Saxne T; Heinegård D; Wollheim FA; Pettersson H
Lancet; 1985 Jul; 2(8447):127-8. PubMed ID: 2862321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
